PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 141 filers reported holding PDL BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 500 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $1,235,000 | -21.6% | 500 | 0.0% | 0.00% | +200.0% |
| Q3 2020 | $1,575,000 | +8.2% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,455,000 | -99.6% | 500 | -98.6% | 0.00% | -99.6% |
| Q1 2020 | $405,912,000 | +21263.8% | 36,834 | +7266.8% | 0.28% | +6825.0% |
| Q2 2019 | $1,900,000 | +20.3% | 500 | 0.0% | 0.00% | +300.0% |
| Q4 2018 | $1,580,000 | +25.4% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $1,260,000 | -1.6% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $1,280,000 | +20.2% | 500 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $1,065,000 | -8.2% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,160,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |